David L. Corbet

No más puestos en curso

70 años

Health Technology

Perfil

David L.
Corbet has been President, Chief Operating Officer and a Director of Matritech, Inc. since October 1993.
He joined Matritech as Executive Vice President in April 1993.
Prior to joining Matritech, Mr. Corbet was President and Chief Operating Officer of T Cell Diagnostics, Inc. from 1991 to April 1993.

Antiguos cargos conocidos de David L. Corbet.

Empresas	Cargo	Fin
MZT Holdings, Inc. MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA.	Director/Miembro de la Junta	20/06/2012
Matritech, Inc. Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services	Presidente	-

Ver el detalle de la experiencia de David L. Corbet.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David L. Corbet.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Matritech, Inc. Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services	Health Technology
MZT Holdings, Inc. MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA.	Health Technology